From oncology to engineering, faculty are partnering with departments across campus to advance healthcare in Wisconsin and beyond.
Drug Delivery
Advancing Treatments for Fibrotic Lung Disease
With a new SEED grant, School of Pharmacy Professor Seungpyo Hong and collaborators are working to reduce treatment toxicity for idiopathic pulmonary fibrosis.
UW Researchers Simplify Production of Promising Targeted Cancer Therapies
A new technique for creating antibody-drug conjugates has already led to a startup company aimed at advancing the technology.
New NIH Grant to Fight Triple-Negative Breast Cancer
With support from the NIH, Assistant Professor Quanyin Hu uses a two-step system to attack triple-negative breast cancer.
New Grant Fuels Pediatric Brain Cancer Treatments
With V Foundation funding, Assistant Professor Quanyin Hu aims to improve a cancer-killing hydrogel to improve outcomes for pediatric GBM patients.
Platelets as Protein Degraders
A cutting-edge platform developed by Assistant Professor Quanyin Hu uses protein-degrading platelets to suppress tumor regrowth and bolster immune response after surgery.
UW–Madison Leading New Research Collaboration Aimed at Treating Lung Scarring Diseases
University of Wisconsin–Madison scientists are poised to gain a better understanding of how to treat a progressive scarring disease of the lungs that kills an estimated 40,000 people every year in the United States.
Nano-Drugs on Bacteria Could Target Difficult-to-Treat Pancreatic Cancer
Employing bacteria to infiltrate that cancerous fortification and deliver drugs could aid treatment for pancreatic cancer, according to newly published findings from a team of University of Wisconsin–Madison researchers.
Assistant Professor Quanyin Hu Honored as Vilas Associate
A competitive Vilas Associates award recognizes Assistant Professor Quanyin Hu’s innovations in cell therapy research and fuels more development.
A Year of Discovery
In the 2020–21 Fiscal Year, School of Pharmacy researchers received six patents to improve drug delivery and discovery.